BRIEF-CSL Says CSL Seqirus & Vaccine Industrial Sign Landmark MoU With Ministry Of Health

Reuters

Oct 30

Oct 30 (Reuters) - CSL Ltd CSL.AX:

CSL SEQIRUS AND VACCINE INDUSTRIAL COMPANY SIGN LANDMARK MEMORANDUM OF UNDERSTANDING WITH MINISTRY OF HEALTH
MOU TO LOCALIZE MANUFACTURING OF CELL-BASED SEASONAL AND PANDEMIC INFLUENZA VACCINES

Further company coverage: CSL.AX

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2579191415"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2579191415\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2579191415?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-30 16:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2579191415","market":"fut","top_or_hot":-1,"title":"BRIEF-CSL Says CSL Seqirus & Vaccine Industrial Sign Landmark MoU With Ministry Of Health","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-CSL Says CSL Seqirus &amp; Vaccine Industrial Sign Landmark MoU With Ministry Of Health</title></head><body><p><span>Oct 30 (Reuters)</span><span> - </span>CSL Ltd <span>CSL.AX</span>:</p><ul><li><p>CSL SEQIRUS AND VACCINE INDUSTRIAL COMPANY SIGN LANDMARK MEMORANDUM OF UNDERSTANDING WITH MINISTRY OF HEALTH</p></li><li><p>MOU TO LOCALIZE MANUFACTURING OF CELL-BASED SEASONAL AND PANDEMIC INFLUENZA VACCINES</p></li></ul><p>Further company coverage: <span>CSL.AX</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-CSL Says CSL Seqirus & Vaccine Industrial Sign Landmark MoU With Ministry Of Health</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-CSL Says CSL Seqirus & Vaccine Industrial Sign Landmark MoU With Ministry Of Health\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-30 16:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-CSL Says CSL Seqirus &amp; Vaccine Industrial Sign Landmark MoU With Ministry Of Health</title></head><body><p><span>Oct 30 (Reuters)</span><span> - </span>CSL Ltd <span>CSL.AX</span>:</p><ul><li><p>CSL SEQIRUS AND VACCINE INDUSTRIAL COMPANY SIGN LANDMARK MEMORANDUM OF UNDERSTANDING WITH MINISTRY OF HEALTH</p></li><li><p>MOU TO LOCALIZE MANUFACTURING OF CELL-BASED SEASONAL AND PANDEMIC INFLUENZA VACCINES</p></li></ul><p>Further company coverage: <span>CSL.AX</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7501","symbol_name":"新冠治疗股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nFWN3WA2I2:1","article_id":"2579191415","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2579191415","pubTimestamp":1761812332,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-CSL Says CSL Seqirus & Vaccine Industrial Sign Landmark MoU With Ministry Of HealthOct 30  - CSL Ltd CSL.AX:CSL SEQIRUS AND VACCINE INDUSTRIAL COMPANY SIGN LANDMARK MEMORANDUM OF UNDERSTANDING WITH MINISTRY OF HEALTHMOU TO LOCALIZE MANUFACTURING OF CELL-BASED SEASONAL AND PANDEMIC INFLUENZA VACCINESFurther company coverage: CSL.AX ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7501":"新冠治疗股","CSL.AU":"CSL LIMITED","BK7511":"ESG概念","BK7067":"生物科技","BK7508":"医药生物股"},"translate_title":"简报-CSL表示CSL Seqirus&Vaccine Industrial与卫生部签署具有里程碑意义的谅解备忘录","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CSL.AU":0.9},"content_text":"BRIEF-CSL Says CSL Seqirus & Vaccine Industrial Sign Landmark MoU With Ministry Of HealthOct 30 (Reuters) - CSL Ltd CSL.AX:CSL SEQIRUS AND VACCINE INDUSTRIAL COMPANY SIGN LANDMARK MEMORANDUM OF UNDERSTANDING WITH MINISTRY OF HEALTHMOU TO LOCALIZE MANUFACTURING OF CELL-BASED SEASONAL AND PANDEMIC INFLUENZA VACCINESFurther company coverage: CSL.AX ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}